SERPINB1 and cystic fibrosis: Ecotin, SERPINB1, camostat mesylate, nelfinavir mesylate, chloromethyl ketone, azithromycin, and ciprofloxacin are factors that could reduce the severity of SARS-CoV-2 in CF patients.